Advocates: Engagement With Patients Key To Long-Term Registry Participation - Inside Health Policy
Regular engagement with patients participating in registries is key to ensuring they continue to participate in long-term follow-up about a disease’s progression or the effectiveness of a treatment, leaders of patient advocate groups who have created effective registries said this week. The advice comes as FDA officials struggle with how to keep patients in registries and are looking at possible incentives.